(VIANEWS) – Shares of Sorrento Therapeutics (NASDAQ: SRNE) jumped by a staggering 28.23% in 14 days from $1.24 to $1.59 at 15:02 EST on Tuesday, after two consecutive sessions in a row of losses. NASDAQ is dropping 0.3% to $11,354.62, following the last session’s upward trend.
Sorrento Therapeutics’s last close was $1.58, 85.73% below its 52-week high of $11.07.
Today’s last reported volume for Sorrento Therapeutics is 5159552 which is 46.06% below its average volume of 9566534.
Sorrento Therapeutics’s Sales
Sorrento Therapeutics’s sales growth is 29% for the current quarter and 85.1% for the next. The company’s growth estimates for the present quarter is a negative 1700% and positive 77.2% for the next.
Sorrento Therapeutics’s Revenue
Year-on-year quarterly revenue growth grew by 13.7%, now sitting on 52.9M for the twelve trailing months.
Sorrento Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.67%, a negative 0.73%, and a positive 4.65%, respectively.
Sorrento Therapeutics’s highest amplitude of average volatility was 3.30% (last week), 5.85% (last month), and 4.65% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Sorrento Therapeutics’s stock is considered to be oversold (<=20).
Sorrento Therapeutics’s Stock Yearly Top and Bottom Value
Sorrento Therapeutics’s stock is valued at $1.59 at 15:02 EST, way below its 52-week high of $11.07 and way higher than its 52-week low of $1.15.
Sorrento Therapeutics’s Moving Average
Sorrento Therapeutics’s worth is way under its 50-day moving average of $1.93 and way under its 200-day moving average of $4.90.
More news about Sorrento Therapeutics (SRNE).